Algert Global’s Edwards Lifesciences EW Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $440K | Buy |
+5,630
| New | +$440K | 0.01% | 959 |
|
|
2025
Q1 | – | Sell |
-11,812
| Closed | -$874K | – | 1222 |
|
|
2024
Q4 | $874K | Sell |
11,812
-52,313
| -82% | -$3.87M | 0.02% | 813 |
|
|
2024
Q3 | $4.23M | Buy |
64,125
+59,509
| +1,289% | +$3.93M | 0.11% | 311 |
|
|
2024
Q2 | $426K | Buy |
4,616
+1,280
| +38% | +$118K | 0.01% | 973 |
|
|
2024
Q1 | $319K | Sell |
3,336
-4,252
| -56% | -$407K | 0.01% | 875 |
|
|
2023
Q4 | $579K | Buy |
7,588
+959
| +14% | +$73.2K | 0.02% | 777 |
|
|
2023
Q3 | $459K | Sell |
6,629
-11,456
| -63% | -$793K | 0.02% | 770 |
|
|
2023
Q2 | $1.71M | Hold |
18,085
| – | – | 0.07% | 448 |
|
|
2023
Q1 | $1.5M | Buy |
18,085
+5,270
| +41% | +$436K | 0.07% | 456 |
|
|
2022
Q4 | $956K | Buy |
12,815
+8,137
| +174% | +$607K | 0.05% | 590 |
|
|
2022
Q3 | $387K | Buy |
4,678
+79
| +2% | +$6.54K | 0.02% | 879 |
|
|
2022
Q2 | $437K | Buy |
+4,599
| New | +$437K | 0.03% | 803 |
|
|
2022
Q1 | – | Sell |
-6,040
| Closed | -$782K | – | 1212 |
|
|
2021
Q4 | $782K | Sell |
6,040
-8,021
| -57% | -$1.04M | 0.1% | 355 |
|
|
2021
Q3 | $1.59M | Buy |
+14,061
| New | +$1.59M | 0.21% | 95 |
|